Lista de obras - Mathilde Kouwenhoven - Dominio Público Uruguay

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

artículo científico publicado en 2006

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

artículo científico publicado en 2012

Chemokines and their receptors in whiplash injury: elevated RANTES and CCR-5

artículo científico publicado en 2001

Chromosome 1p loss evaluation in anaplastic oligodendrogliomas

article

Cytokines in multiple sclerosis: methodological aspects and pathogenic implications

artículo científico publicado en 2002

Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression

artículo científico publicado en 2001

Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

artículo científico publicado en 2005

Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis

artículo científico publicado en 2002

Enzyme-linked immunospot assays provide a sensitive tool for detection of cytokine secretion by monocytes.

artículo científico publicado en 2001

First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response

artículo científico publicado en 2010

Gene expression profiles associated with treatment response in oligodendrogliomas.

artículo científico publicado en 2005

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

artículo científico publicado en 2010

IL-12 ELISPOT ASSAYS TO DETECT AND ENUMERATE IL-12 SECRETING CELLS

artículo científico publicado en 2000

IL-12/IL-12R system in multiple sclerosis

artículo científico publicado en 2001

Intratumoral distribution of 1p loss in oligodendroglial tumors.

artículo científico publicado en 2007

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

artículo científico publicado en 2009

Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades

artículo científico publicado en 2022

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.

artículo científico publicado en 2010

Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke

artículo científico publicado en 2001

Metalloproteinases and their tissue inhibitors in multiple sclerosis.

artículo científico publicado en 1999

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

artículo científico publicado en 2009

Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis

scientific article published on 01 May 2002

Monocytes in multiple sclerosis: phenotype and cytokine profile

artículo científico publicado en 2001

Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.

artículo científico publicado en 2000

Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines

artículo científico publicado en 1999

Multiple sclerosis:

artículo científico publicado en 2000

Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables

artículo científico publicado en 2003

Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.

artículo científico publicado en 2001

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cance

artículo científico publicado en 2013

Non-TH1 cytokines are augmented systematically early in Guillain-Barre syndrome

artículo científico publicado en 2002

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome

artículo científico publicado en 2007

Phenotypes and cytokine profiles of enriched blood dendritic cells in healthy individuals

artículo científico publicado en 2000

Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group

artículo científico publicado en 2012

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

artículo científico publicado en 2009

Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections

artículo científico publicado en 2002

Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma

artículo científico publicado en 2008

Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours

artículo científico

Systemic Immune Response in Whiplash Injury and Ankle Sprain: Elevated IL-6 and IL-10

artículo científico publicado en 2001

The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation

scientific article published on 01 March 2019

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

scientific article published on 01 July 2019

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study

artículo científico publicado en 2019

Lista de obras de Mathilde Kouwenhoven

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Chemokines and their receptors in whiplash injury: elevated RANTES and CCR-5

Chromosome 1p loss evaluation in anaplastic oligodendrogliomas

Cytokines in multiple sclerosis: methodological aspects and pathogenic implications

Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression

Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis

Enzyme-linked immunospot assays provide a sensitive tool for detection of cytokine secretion by monocytes.

First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response

Gene expression profiles associated with treatment response in oligodendrogliomas.

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

IL-12 ELISPOT ASSAYS TO DETECT AND ENUMERATE IL-12 SECRETING CELLS

IL-12/IL-12R system in multiple sclerosis

Intratumoral distribution of 1p loss in oligodendroglial tumors.

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.

Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke

Metalloproteinases and their tissue inhibitors in multiple sclerosis.

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis

Monocytes in multiple sclerosis: phenotype and cytokine profile

Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.

Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines

Multiple sclerosis:

Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables

Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cance

Non-TH1 cytokines are augmented systematically early in Guillain-Barre syndrome

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome

Phenotypes and cytokine profiles of enriched blood dendritic cells in healthy individuals

Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections

Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma

Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours

Systemic Immune Response in Whiplash Injury and Ankle Sprain: Elevated IL-6 and IL-10

The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study